Janus Henderson Group PLC Edgewise Therapeutics, Inc. Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
A detailed history of Janus Henderson Group PLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 2,607,299 shares of EWTX stock, worth $91.8 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,607,299
Previous 1,805,312
44.42%
Holding current value
$91.8 Million
Previous $32.9 Million
42.61%
% of portfolio
0.03%
Previous 0.02%
Shares
14 transactions
Others Institutions Holding EWTX
# of Institutions
163Shares Held
97.8MCall Options Held
45.7KPut Options Held
13.1K-
Orbimed Advisors LLC San Diego, CA15MShares$529 Million6.52% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$314 Million2.42% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$212 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY5.84MShares$206 Million1.4% of portfolio
-
Novo Holdings Hellerup, G75.55MShares$195 Million10.36% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $2.22B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...